Table 1 Laboratory characteristics of the AML group (n = 91)
| Â | Value |
|---|---|
Total leukocytic count (× 103/mm3) | 38.9 (1.0–440.0) |
Hemoglobin concentration (gm/dL) | 8.0 ± 1.8 |
Platelet count (× 103/mm3) | 35.0 (5.0–297.0) |
Peripheral blood blasts (%) | 51.0 (0.0–98.0) |
Bone marrow blasts (%) | 70.0 (0.0–97.0) |
FAB classification | |
 M1 | 11 (12.1%) |
 M2 | 38 (41.8%) |
 M4 | 31 (34.1%) |
 M5 | 10 (11.0%) |
 M7 | 1 (1.1%) |
BM cellularity | |
 Hypercellular | 68 (74.7%) |
 Normocellular | 12 (13.2%) |
 Hypocellular | 5 (5.5%) |
FLT3-ITD mutation | 14 (15.4%) |
NPM mutation | 9 (39.1%) |
Molecular markers | |
 −ve | 77 (84.6%) |
 +ve | 14 (15.4%) |
  inv (16) | 8 (8.8%) |
  t(8, 21) | 1 (1.1%) |
  t(8, 21), t(9, 22) | 1 (1.1%) |
  t(8:21) | 4 (4.4%) |
Genetics | |
 Abnormal | 24 (26.4%) |
 Normal | 67 (73.6%) |
Genetic risk (ELN) | |
 Favorable | 18 (19.8%) |
 Intermediate | 51 (56.0%) |
 Adverse | 22 (24.2%) |